Filing Analysis
Regulation FD Disclosure
Filed Mar 06, 2026
LOW
PMV Pharmaceuticals, Inc. announced its financial results for the fiscal year ended December 31, 2025, via a press release on March 6, 2026.
Key Facts
- The company reported financial results for the full year ended December 31, 2025.
- The announcement was made on March 6, 2026.
- The financial information was furnished under Item 2.02 and is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- Michael Carulli, CFO, signed the report.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.